Islet transplantation for diabetic rats through the spleen

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 2, 2005, Pages 203-206

  Cheng, Ying ^a   Zhang, Jia Lin ^a   Liu, Yong Feng ^a   Li, Tie Min ^a   Zhao, Ning ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Islet transplantation; Spleen

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CENTRIFUGATION; CONTROLLED STUDY; DIABETES MELLITUS; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; NONHUMAN; ORGAN DONOR; PANCREAS FUNCTION; PANCREAS ISLET TRANSPLANTATION; PORTAL HYPERTENSION; POSTOPERATIVE PERIOD; RAT; RAT STRAIN; RECIPIENT; SPLEEN;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; GRAFT SURVIVAL; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; PANCREATIC FUNCTION TESTS; PROBABILITY; RATS; RATS, WISTAR; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPLEEN; TRANSPLANTATION, ISOGENEIC;

EID: 20344403054     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hara M, Yin D, Dizon RF, Shen J, Chong AS, Bindoksa VP. A mouse model for studying intrahepatic islet transplantation. Transplantation 2004;78:615-618.
2. Hirshberg B, Mog S, Patterson N, Leconate J, Harlan DM. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression. J Clin Endocrinol Metab 2002;87:5424-5429.
3. Bhargava R, Senior PA, Ackerman TE, Ryan EA, Paty BW, Lakey JR, et al. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 2004;53: 1311-1317.
4. Fontaine MJ, Fan W. Islet cell transplantation as a cure for insulin dependent diabetes: current improvements in preserving islet cell mass and function. Hepatobiliary Pancreat Dis Int 2003;2:170-179.
5. Hyon SH, Ceballos MC, Barbich M, Groppa R, Grosembacher L, Vieiro MM, et al. Effect of the embolization of completely unpurified islets on portal vein pressure and hepatic biochemistry in clinical practice. Cell Transplant 2004;13:61-65.
6. Sawada T, Matsumoto I, Nakano M, Kirchhof N, Sutherland DE, Herring BJ. Improved islet yield and function with ductal Injection of University Wisconsin solution before pancreas preservation. Transplantation 2003;75:1965-1969.
7. Bucher P, Bosco D, Mathe Z, Matthey-Doret D, Andres A, Kurfuerst M, et al. Optimization of neutral protease to collagenase activity ratio for islet of Langerhans isolation. Transplant Proc 2004;36:1145-1146
8. Eckhard M, Brandhorst D, Brandhorst H, Brendel MD, Bretzel RG. Optimization in osmolality and range of density of a continuous ficoll-sodium-diatrizoate gradient for isopycnic purification of isolated human islets. Transplant Proc 2004;36: 2849-2854.
9. Shiroi A, Yoshikawa M, Yokota H, Fukui H, Ishizaka S, Tatsumi K, et al. Identification of insulin-producing cells derived from embryonic stem cells by zinc-chelating dithizone. Stem Cells 2002;20:284-292.
10. Nagata N, Gu Y, Hori H, Balamurugan AN, Touma M, Kawakami Y, et al. Evaluation of insulin secretion of isolated rat islets cultured in extracellular matrix. Cell Transplant 2001 10:447-451.
11. Russell JC, Graham SE, Dolphin PJ. Glucose tolerance and insulin resistance in the JCR: LA-corpulent rat: effect of miglitol (Bay m1099). Metabolism 1999;48:701-706.
12. Fiorina P, Folli F, Maffi P, Placidi C, Venturini M, Finzi G, et al. Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation 2003;75:1296-1301.
13. Sutherland DE. Current status of beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus. Transplant Proc 2003;35:1625-1627.
14. Sutherland DE, Gruessner R, Kandswamy R, Humar A, Hering B, Gruessner A. Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach. Transplant Proc 2004;36:1697-1699.
15. Cai SR, He YL, Lei ZM, Zhang PM, Guo Y. The effect of FasL gene transfer to islet cells on pancreatic islet allografts. Hepatobiliary Pancreat Dis Int 2003;2:308-312.
16. Cui YF, Ma M, Wang ZD, Zhang L, Hu ZL, Han DE. Prevention of central cell damage to isolated islets of Langerhans in hamsters by low temperature preconditioning. Hepatobiliary Pancreat Dis Int 2005;4:139-143.
17. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardellic, Oliver R, et al. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2003,50:1983-1991.
18. Scharp DW. Clinical feasibility of islet transplantation. Transplant Proc 1984;16:820-825.
19. Venturini M, Angeli E, Maffi P, Fiorina P, Bertuzzi F, Salvioni M, et al. Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US. Radiology 2005;234:617-624.
20. Bucher P, Mathe Z, Bosco D, Becker C, Kessler L, Greget M, et al. Morbidity associated with intraportal islet transplantation. Transplant Proc 2004;36:1119-1120.